| Ms Elizabeth A Phelps, NP | |
|
4501 Sand Creek Rd, Employee Health 3rd Fl, Antioch, CA 94531 | |
| (925) 813-6468 | |
| Not Available |
| Full Name | Ms Elizabeth A Phelps |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Location | 4501 Sand Creek Rd, Antioch, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801970405 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Elizabeth A Phelps, NP 4501 Sand Creek Rd, Employee Health 3rd Fl, Antioch, CA 94531 Ph: (925) 813-6468 | Ms Elizabeth A Phelps, NP 4501 Sand Creek Rd, Employee Health 3rd Fl, Antioch, CA 94531 Ph: (925) 813-6468 |
News Archive
Care Improvement Plus, operator of one of the largest special needs plans in Texas, is standing by its commitment to serve chronically ill and underserved Medicare beneficiaries with the release of its 2011 Medicare health plan benefits in preparation for the upcoming Medicare annual election period, which begins November 15th.
Amarin Corporation plc today announced it has closed its $70 million private placement. The transaction was led by existing investor, Fountain Healthcare Partners, on behalf of funds affiliated with other existing investors Sofinnova Ventures, Orbimed Advisors and Longitude Capital. The new investor group was led by funds affiliated with Abingworth LLP and included APG Asset Management, Great Point Partners, Tavistock Life Sciences Company and RA Capital. Cowen and Company, LLC acted as the exclusive placement agent for the transaction.
Mount Sinai has officially opened a new center to treat and research tic and obsessive-compulsive disorders (OCD) in individuals of all ages. The opening coincides with a significant revision in the psychiatry field's manual of mental disorders, which will now recognize OCD with its own category, rather than classifying it as an anxiety disorder.
Boehringer Ingelheim Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration granted approval of Praxbind (idarucizumab). PRAXBIND is indicated for patients treated with Pradaxa (dabigatran etexilate mesylate), when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures or in life-threatening or uncontrolled bleeding.
Children with symptoms of anxiety and depression may have an increased tendency to use ecstasy in adolescence or young adulthood, finds a study published online by the British Medical Journal.
› Verified 9 days ago
Dr. Lauren Shirvanee, D.O. General Practice Medicare: Not Enrolled in Medicare Practice Location: 3903 Lone Tree Way, Suite 210, Antioch, CA 94509 Phone: 925-754-7866 | |
William Lumba Quismorio, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 3707 Sunset Ln, Antioch, CA 94509 Phone: 925-522-0124 Fax: 925-522-0133 |